There is a high prevalence of symptomatic coronary artery disease (6.4 million patients) in the United States, with an annual incidence of about 400,000. In other studies, angina is not optimally controlled despite optimal medical management and coronary revascularization. This condition is termed refractory angina. Guidelines for management of refractory angina include: education, rehabilitation, cognitive behavioral therapy, spinal cord stimulation, transcutaneous electrical nerve stimulation, left stellate ganglion block, thoracoscopic sympathectomy, angiogenesis, and surgical transmyocardial revascularization, among others.
American Cardio Care uses Enhanced External CounterPulsation (EECP) as an option to relieve your angina when all other treatments have failed or aren't right for you. It is a non-invasive cardio vascular system that provides cardio vascular treatment and therapy. It can help your blood vessels make a natural bypass around narrowed or blocked arteries that cause your chest pain.
EECP improves anginal symptoms and exercise tolerance, and reduces nitroglycerin use in patients with chronic, stable angina. EECP has also been shown to be safe and beneficial in patients with symptomatic stable congestive heart failure. In June 2002, the FDA approved EECP therapy for heart failure patients. EECP Treatment of vessel blockages has also been useful in management of erectile dysfunction as well as stroke patients.
For kidney disease and other diseases it can actually reverse the condition.